Skip to content

Jianan Bao

2 papers in the library · 231 citations · publishing 2022

Papers

The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics.

World psychiatry : official journal of the World Psychiatric Association (WPA) June 1, 2022 Paolo Fusar-Poli, Andrés Estradé, Giovanni Stanghellini et al. 225 citations

Psychosis unfolds through distinct stages, each with its own core existential experiences. Early phases (premorbid and prodromal) involve loss of common sense, perplexity, lack of immersion in the world, heightened salience, a feeling that something important is about to happen, perturbation of the sense of self, and a need to hide inner turmoil. The first episode brings transitory relief from delusions, intense self-referentiality, permeated self-world boundaries, internal noise, and dissolution of self with social withdrawal. Later stages (relapsing and chronic) involve grieving losses, feeling split, and struggling to accept inner chaos, a new self, diagnosis, and uncertain future. Treatment experiences include both positive and negative aspects, with recovery understood as reconstructing personhood and re-establishing bonds toward meaningful goals.

Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results

Journal of Neuropsychiatry May 17, 2022 Matthew Butler, Mathieu Seynaeve, Abigail Bradley‐Westguard et al. 6 citations

Almost half of people with functional neurological disorder (FND) report having tried legal psychoactive substances—nicotine, alcohol, and cannabidiol—to manage their symptoms, finding them modestly effective. Fifteen percent have used illicit substances, mostly cannabis, reporting moderate effectiveness and minimal side effects. Many respondents (46%) would be willing to try medically supervised psychedelic therapy if proven safe and effective. The findings highlight that people with FND often seek alternative symptom management outside usual medical care and suggest that further research into novel treatments, including psychedelics, may be warranted.